General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0MSZBZ
ADC Name
BB-1709
Synonyms
BB 1709; BB1709
   Click to Show/Hide
Organization
Baili Sikang Biomedicine (Hangzhou) Co., Ltd.
Drug Status
Phase 1
Indication
In total 1 Indication(s)
Solid tumors [ICD11:2A00-2A0Z|2B50-2F9Z]
Phase 1
Antibody Name
Undisclosed
Antigen Name
5'-nucleotidase (NT5E)
 Antigen Info 
Payload Name
Undisclosed
Linker Name
Undisclosed

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.